2025. IL-17 Inhibition vs IL-23 Inhibition for Psoriatic Arthritis: An Ongoing Debate. Canadian Rheumatology Today. 2, 2 (août 2025), 4–14. DOI:https://doi.org/10.58931/crt.2025.2262.